VIJANDRE, SHERYL G.

BSN III-I

DRUG STUDY - CARVEDILOL

DRUG MECHANISM OF INDICATIONS ADVERSE AND NURSING MONITORING

ACTION SIDE EFFECTS RESPONSIBILITIES PARAMETERS

GENERIC NAME Blocks stimulation - Treatment of mild to CNS: dizziness, fatigue, Check the bp and heart rate Monitor BP and
Carvedilol of beta1 severe CHF of weakness, anxiety, before giving the medication heart rate
depression,
(myocardial) and ischemic or
drowsiness, insomnia,
BRAND NAME beta2 (pulmonary, cardiomyopathic memory loss, mental
Give with food to Monitor patient
Glovedol vascular, and origin with digitalis, status changes, decrease orthostatic for any sign of
uterine)- diuretics, ACE nervousness, hypotension and hepatic
CLASSIFICATION adrenergic inhibitors nightmares adverse effects. impairment
Alpha- and beta- receptor sites. EENT: blurred vision, (pruritus, dark
Adrenergic blocker / Also has alpha1 CONTRAINDICATIONS dry eyes, Monitor for orthostatic urine or
Antihypertensive blocking activity, intraoperative floppy hypotension and stools, anorexia,
which may result iris syndrome, nasal provide safety jaundice, pain);
DOSAGE in orthostatic History of serious stuffiness precautions. arrange for LFTs
hypersensitivity Resp: bronchospasm,
6.25 mg 1 tab OD hypotension. and discontinue
reaction (Stevens- wheezing
CV: BRADYCARDIA, HF,
Advise patient to report drug if
ROUTE Decreased heart Johnson syndrome, difficulty of tests indicate liver
PULMONARY EDEMA
PO rate and BP. angioedema, breathing, swelling of injury.
GI: diarrhea,
Improved cardiac anaphylaxis); constipation, nausea extremities, changes Do not restart
output, slowing of Pulmonary edema; GU: erectile in color of stool or carvedilol
the progression of Cardiogenic shock; dysfunction, ↓ libido urine, very slow heart
HF and decreased Bradycardia, heart block Derm: STEVENS- rate, continued
risk of death. or sick sinus syndrome JOHNSON SYNDROME, dizziness
(unless a pacemaker is TOXIC EPIDERMAL
in place); NECROLYSIS, itching,
Do not
Uncompensated HF rashes, urticaria
Endo: hyperglycemia,
discontinue drug
requiring IV inotropic abruptly after chronic
hypoglycemia
agents (wean before therapy; taper drug gradually
MS: arthralgia, back
starting carvedilol); pain, muscle cramps over 2 weeks with
Severe hepatic Neuro: paresthesia monitoring.
impairment;
Asthma or other
bronchospastic
disorders.)